Diabetes Care Drugs & Devices Market - 2024-2033
Description
Diabetes Care Drugs & Devices Market Overview:
The Diabetes Care Drugs & Devices Market was valued at US$ 119.86 billion in 2024 and is anticipated to reach US$ 244.46 billion by 2033, at a CAGR of 0.083 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Diabetes Care Drugs & Devices Market.
This report delivers a comprehensive overview of the Diabetes Care Drugs & Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Diabetes Care Drugs & Devices Market. The Diabetes Care Drugs & Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
Diabetes Care Drugs & Devices Market Scope:
Key Players
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Medtronic plc
• Terumo Corporation
• B. Braun SE
• Merck & Co., Inc.
• Novo Nordisk A/S.
• Eli Lilly and Company
• Boehringer Ingelheim Pharmaceuticals, Inc.
• Insulet Corporation LIST NOT EXHAUSTIVE
Major Highlights
This report delivers a comprehensive overview of the Diabetes Care Drugs & Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Diabetes Care Drugs & Devices Market. The Diabetes Care Drugs & Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
The Diabetes Care Drugs & Devices Market was valued at US$ 119.86 billion in 2024 and is anticipated to reach US$ 244.46 billion by 2033, at a CAGR of 0.083 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Diabetes Care Drugs & Devices Market.
This report delivers a comprehensive overview of the Diabetes Care Drugs & Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Diabetes Care Drugs & Devices Market. The Diabetes Care Drugs & Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
Diabetes Care Drugs & Devices Market Scope:
Key Players
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Medtronic plc
• Terumo Corporation
• B. Braun SE
• Merck & Co., Inc.
• Novo Nordisk A/S.
• Eli Lilly and Company
• Boehringer Ingelheim Pharmaceuticals, Inc.
• Insulet Corporation LIST NOT EXHAUSTIVE
Major Highlights
This report delivers a comprehensive overview of the Diabetes Care Drugs & Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Diabetes Care Drugs & Devices Market. The Diabetes Care Drugs & Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
Table of Contents
219 Pages
- 1. Market Introduction and Scope
- 1.1. Objectives of the Report
- 1.2. Report Coverage & Definitions
- 1.3. Report Scope
- 2. Executive Insights and Key Takeaways
- 2.1. Market Highlights and Strategic Takeaways
- 2.2. Key Trends and Future Projections
- 2.3. Snippet by Product Type
- 2.4. Snippet by Application
- 2.5. Snippet by End-User
- 2.6. Snippet by Region
- 3. Dynamics
- 3.1. Impacting Factors
- 3.1.1. Drivers
- 3.1.1.1. Rising Prevalence of Diabetes
- 3.1.1.2. Rising Advancements in Diabetes Devices
- 3.1.2. Restraints
- 3.1.2.1. High Cost of Diabetes Care Devices
- 3.1.2.2. Side Effects Associated with Diabetes Drugs
- 3.1.3. Opportunity
- 3.1.3.1. Advancements in Diabetes Wearables and Apps
- 3.1.4. Impact Analysis
- 4. Strategic Insights and Industry Outlook
- 4.1. Market Leaders and Pioneers
- 4.1.1. Emerging Pioneers and Prominent Players
- 4.1.2. Established leaders with largest selling Brand
- 4.1.3. Market leaders with established Product
- 4.2. CXO Perspectives
- 4.3. Latest Developments and Breakthroughs
- 4.4. Case Studies/Ongoing Research
- 4.5. Regulatory and Reimbursement Landscape
- 4.5.1. North America
- 4.5.2. Europe
- 4.5.3. Asia Pacific
- 4.5.4. Latin America
- 4.5.5. Middle East & Africa
- 4.6. Porter’s Five Forces Analysis
- 4.7. Supply Chain Analysis
- 4.8. Patent Analysis
- 4.9. SWOT Analysis
- 4.10. Unmet Needs and Gaps
- 4.11. Recommended Strategies for Market Entry and Expansion
- 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
- 4.13. Pricing Analysis and Price Dynamics
- 4.14. Key Opinion Leaders
- 4.15. Pipeline Analysis
- 5. Diabetes Care Drugs & Devices Market, By Product Type
- 5.1. Introduction
- 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 5.1.2. Market Attractiveness Index, By Product Type
- 5.2. Diabetes Devices*
- 5.2.1. Introduction
- 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 5.2.3. Blood Glucose Monitoring Devices
- 5.2.3.1. Continuous Glucose Monitoring Devices
- 5.2.3.2. Self-Monitoring Devices
- 5.2.3.2.1. Blood Glucose Meters
- 5.2.3.2.2. Testing Strips
- 5.2.3.2.3. Lancets
- 5.2.4. Insulin Delivery Devices
- 5.2.4.1. Insulin Pumps
- 5.2.4.2. Insulin Pens
- 5.2.4.3. Insulin Syringes
- 5.2.4.4. Others
- 5.3. Diabetes Drugs
- 5.3.1. Insulin
- 5.3.1.1. Slow-acting Insulin
- 5.3.1.2. Intermediate-acting Insulin
- 5.3.1.3. Fast-acting Insulin
- 5.3.1.4. Others
- 5.3.2. Oral Anti-Diabetic Drugs
- 5.3.2.1. Biguanides
- 5.3.2.2. Sulfonylureas
- 5.3.2.3. Thiazolidinediones
- 5.3.2.4. Alpha-Glucosidase Inhibitors
- 5.3.2.5. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- 5.3.2.6. Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors
- 5.3.2.7. Others
- 5.3.3. Non-Insulin Injectable Drugs
- 5.3.3.1. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
- 5.3.3.2. Amylin Analogues
- 5.3.4. Combination Drugs
- 5.3.5. Others
- 6. Diabetes Care Drugs & Devices Market, By Application
- 6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 6.1.2. Market Attractiveness Index, By Application
- 6.2. Type-1 Diabetes*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.3. Type-2 Diabetes
- 6.4. Gestational Diabetes
- 6.5. Prediabetes
- 7. Diabetes Care Drugs & Devices Market, By End-User
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 7.1.2. Market Attractiveness Index, By End-User
- 7.2. Hospitals*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.3. Specialty Clinics
- 7.4. Homecare Settings
- 7.5. Diagnostic Centers
- 7.6. Others
- 8. Diabetes Care Drugs & Devices Market, By Regional Market Analysis and Growth Opportunities
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 8.1.2. Market Attractiveness Index, By Region
- 8.2. North America
- 8.2.1. Introduction
- 8.2.2. Key Region-Specific Dynamics
- 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 8.2.6.1. U.S.
- 8.2.6.2. Canada
- 8.2.6.3. Mexico
- 8.3. Europe
- 8.3.1. Introduction
- 8.3.2. Key Region-Specific Dynamics
- 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 8.3.6.1. Germany
- 8.3.6.2. U.K.
- 8.3.6.3. France
- 8.3.6.4. Spain
- 8.3.6.5. Italy
- 8.3.6.6. Rest of Europe
- 8.4. South America
- 8.4.1. Introduction
- 8.4.2. Key Region-Specific Dynamics
- 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 8.4.6.1. Brazil
- 8.4.6.2. Argentina
- 8.4.6.3. Rest of South America
- 8.5. Asia-Pacific
- 8.5.1. Introduction
- 8.5.2. Key Region-Specific Dynamics
- 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 8.5.6.1. China
- 8.5.6.2. India
- 8.5.6.3. Japan
- 8.5.6.4. South Korea
- 8.5.6.5. Rest of Asia-Pacific
- 8.6. Middle East and Africa
- 8.6.1. Introduction
- 8.6.2. Key Region-Specific Dynamics
- 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9. Competitive Landscape and Market Positioning
- 9.1. Competitive Overview and Key Market Players
- 9.2. Market Share Analysis and Positioning Matrix
- 9.3. Strategic Partnerships, Mergers & Acquisitions
- 9.4. Key Developments in Product Portfolios and Innovations
- 9.5. Company Benchmarking
- 10. Company Profiles
- 10.1. F. Hoffmann-La Roche Ltd.*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio and Description
- 10.1.3. Financial Overview
- 10.1.4. Key Developments
- 10.1.5. SWOT Analysis
- 10.2. Abbott Laboratories
- 10.3. Medtronic plc
- 10.4. Terumo Corporation
- 10.5. B. Braun SE
- 10.6. Merck & Co., Inc.
- 10.7. Novo Nordisk A/S.
- 10.8. Eli Lilly and Company
- 10.9. Boehringer Ingelheim Pharmaceuticals, Inc.
- 10.10. Insulet Corporation LIST NOT EXHAUSTIVE
- 11. Assumption and Research Methodology
- 11.1. Data Collection Methods
- 11.2. Data Triangulation
- 11.3. Forecasting Techniques
- 11.4. Data Verification and Validation
- 12. Appendix
- 12.1. About Us and Services
- 12.2. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
